¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"erythrocyte aggregation"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® ESR(Erythrocyte Sedimentation Rate) ÇÑ±Û ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ
¼³¸í   
  Ç÷¾×ÀÌ ÀÀ°íµÇ´Â °ÍÀ» ¹æÁöÇϴ Ç×ÀÀ°íÁ¦¸¦ ³ÖÀº Ç÷¾×À» Ä§°­¿ë À¯¸®°ü¿¡ ³Ö¾î °¡¸¸È÷ ¼¼¿ö µÎ¾úÀ» ¶§ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â ¼Óµµ¸¦ À̸£´Â ¸»ÀÌ´Ù. 1918³â ½º¿þµ§ÀÇ º´¸®ÇÐÀÚ ÆÄ·¹¿ì½ºÀǠâ¾È¿¡ ÀÇÇÑ °ÍÀÌ´Ù. ÃøÁ¤¹æ¹ýÀ¸·Î ¿©·¯ °¡Áö°¡ Àִµ¥, ±¹Á¦Ç¥ÁعýÀ¸·Î´Â 1973³â ¿þ½ºÅͱ׷»¹ýÀÇ 1½Ã°£¹ýÀÌ ¼±Á¤µÇ¾úÀ¸¸ç, 1977³â ±×°ÍÀ» °³Á¤ÇÏ¿© °¢±¹¿¡¼­ ¾²µµ·Ï ±ÇÀåÇϰí ÀÖ´Ù. 1½Ã°£ ÈĠħ°­¿ë À¯¸®°ü À§ÂÊÀÇ Ç÷Àå±âµÕÀÇ ³ôÀ̸¦ mm·Î Àоî, ±×°ÍÀ» ÀûÇ÷±¸Ä§°­ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ¸¸¾à Ç÷Àå°ú ÀûÇ÷±¸ÀÇ °æ°è°¡ ¼±¸íÇÏÁö ¸øÇÑ °æ¿ì, ÀûÇ÷±¸ÀÇ ¹Ðµµ°¡ ±× ÀÌÇÏ¿¡¼­´Â ÀÏÁ¤ÇÏ´Ù°í ¿©°ÜÁö´Â °÷ÀÇ ´«±ÝÀ» Àоî ÀûÇ÷±¸Ä§°­ÀÇ 1½Ã°£°ªÀ¸·Î ÇÑ´Ù. ÃøÁ¤ ¶§ÀÇ ½Ç³»¿Âµµ´Â 18~25µµ·Î ÇÑ´Ù. ÀϹÝÀûÀ¸·Î À̺¸´Ù ¿Âµµ°¡ ³ôÀº °æ¿ì´Â Ç÷ħ¹ÝÀÀÀÌ ÃËÁøµÇ¸ç, ³·Àº °æ¿ì´Â ´Ê¾îÁø´Ù. Á¤»ó °ªÀº 2~10mm(³²ÀÚ), 3~15mm(¿©ÀÚ)À̸ç 15¼¼ ÀÌÇÏÀÇ ¾î¸°ÀÌ, 50¼¼ ÀÌ»óÀÇ °í·ÉÀÚ¿¡¼­´Â ¾à°£ ³ô´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aggregation
    ÀÀÁý
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • basophilic erythrocyte
    È£¿°±âÀûÇ÷±¸
  • dimorphic erythrocyte
    µÎÇüÅÂÀûÇ÷±¸, ÀÌ»ó¼ºÀûÇ÷±¸
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte ghost
    ÀûÇ÷±¸Çã±úºñ
  • erythrocyte indices
    ÀûÇ÷±¸Áö¼ö
  • erythrocyte sedimentation
    ÀûÇ÷±¸Ä§°­
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ
  • fragmented erythrocyte
    Á¶°¢ÀûÇ÷±¸, ºÐ¿­ÀûÇ÷±¸
  • free erythrocyte porphyrin
    À¯¸®ÀûÇ÷±¸Æ÷¸£ÇǸ°
  • frozen erythrocyte
    µ¿°áÀûÇ÷±¸
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • hyperchromic erythrocyte
    °í»ö¼ÒÀûÇ÷±¸
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aggregation
    ÀÀÁý
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • erythrocyte
    ÀûÇ÷±¸
  • nucleated erythrocyte
    À¯ÇÙÀûÇ÷±¸
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aggregation
    ÀÀÁý
  • aggregation defect
    ÀÀÁý°áÇÔ
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • granulocyte-erythrocyte antigen
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • basophilic erythrocyte
    È£¿°±âÀûÇ÷±¸
  • coated erythrocyte
    ÇǸ·ÀûÇ÷±¸
  • crenated erythrocyte
    Å鳯ÀûÇ÷±¸
  • dimorphic erythrocyte
    µÎ¸ð¾çÀûÇ÷±¸, ÀÌ»ó¼ºÀûÇ÷±¸
  • median erythrocyte diameter
    Á¤ÁßÀûÇ÷±¸Áö¸§
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte ghost
    ÀûÇ÷±¸Çã±úºñ
  • erythrocyte sedimentation
    ÀûÇ÷±¸Ä§Àü
  • erythrocyte stippling
    ÀûÇ÷±¸¹ÝÁ¡
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
  • erythrocyte sedimentation reaction
    ÀûÇ÷±¸Ä§°­¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aggregation
    ÁýÇÕ(ó¢ùê), ÀÀ±«(ëêÎÔ)
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • platelet,aggregation
    ÀÀÁý(ëêó¢), ÀÀ±«(ëêÎÔ)
  • agglutination of erythrocyte
    ÀûÇ÷±¸ÀÀÁý
  • anisocytic erythrocyte
    ºÎµ¿¼¼Æ÷¼º ÀûÇ÷±¸
  • fragmented erythrocyte
    ºÐ¿­ÀûÇ÷±¸
  • free erythrocyte porphyrin
    À¯¸®ÀûÇ÷±¸Æ÷¸£ÇǸ°
  • globulin-coated erythrocyte
    ±Û·ÎºÒ¸°ÇǸ·<--¿Ü¸·>ÀûÇ÷±¸
  • granulocyte-erythrocyte antigens
    °ú¸³±¸ÀûÇ÷±¸Ç׿ø
  • hyperchromic erythrocyte
    °í»ö¼Ò¼º ÀûÇ÷±¸(¡­îåúìϹ).
  • hypochromic erythrocyte
    Àú»ö¼Ò¼º ÀûÇ÷±¸(¡­îåúìϹ).
  • hypochromic erythrocyte
    Àú»ö¼Ò¼º ÀûÇ÷±¸(?ËøÌ´Ë´).
  • immature erythrocyte
    ¹Ì¼÷ÀûÇ÷±¸.
  • immunoglobulin-coated erythrocyte
    ¸é¿ª±Û·ÎºÒ¸°ºÎÂøÀûÇ÷±¸
  • plasma membrane of erythrocyte
    ÀûÇ÷±¸ÇüÁú¸·
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intravascular erythrocyte aggregation =IEA
    Ç÷°ü³»ÀûÇ÷±¸ÀÀÁý(?ËøÌ´Ë´Ëô̤).
  • aggregation
    ÁýÇÕ(ó¢ùê), ÀÀ±«(ëêÎÔ)
  • aggregation defect
    ÀÀÁý°áÇÔ
  • platelet aggregation
    Ç÷¼ÒÆÇÀÀÁý
  • platelet,aggregation
    ÀÀÁý(ëêó¢), ÀÀ±«(ëêÎÔ)
  • ristocetin aggregation test
    ¸®½ºÅ似ƾÀÀÁý½ÃÇè(¡­ëêó¢ãËúÐ)
  • agglutination of erythrocyte
    ÀûÇ÷±¸ÀÀÁý
  • anisocytic erythrocyte
    ºÎµ¿¼¼Æ÷¼º ÀûÇ÷±¸
  • basophilic erythrocyte
    È£¿°±â¼º ÀûÇ÷±¸(?ËøÌ´Ë´).
  • coated erythrocyte
    ÇǸ·ÀûÇ÷±¸
  • crenated erythrocyte
    µÐ°ÅÄ¡»ó ÀûÇ÷±¸.
  • dimorphic erythrocyte
    ÀÌ»ó¼º(ì£ßÓàõ) ÀûÇ÷±¸
  • dysmorphic erythrocyte
    ÀÌÇüÀûÇ÷±¸
  • elliptical erythrocyte
    Ÿ¿øÀûÇ÷±¸
  • erythrocyte
    ÀûÇ÷±¸
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Aggregation defect
    ÀÀÁý°áÇÔ
    [¿¾ ¿ë¾î] ÀÀÁý¼º°áÇÔ
  • Polychromatophilic erythrocyte
    ¹µ»öµëÀûÇ÷±¸
    [¿¾ ¿ë¾î] ´Ù¿°¼ºÀûÇ÷±¸
  • Stroma of erythrocyte
    ÀûÇ÷±¸¹öÆÀÁú
    [¿¾ ¿ë¾î] ÀûÇ÷±¸ÁöÁú
  • Plasma membrane of erythrocyte
    ÀûÇ÷±¸ÇüÁú¸·
    [¿¾ ¿ë¾î] ÀûÇ÷±¸ÇüÁú¸·
  • Erythrocyte
    ÀûÇ÷±¸
    [¿¾ ¿ë¾î] ÀûÇ÷±¸
  • Erythrocyte ghost
    ÀûÇ÷±¸Çã±úºñ
    [¿¾ ¿ë¾î] Ç÷¿µ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • familial aggregation
    °¡Á·ÁýÀû¼º
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte ghost
    ÀûÇ÷±¸(îåúìϹ) ºó²®Áú
  • erythrocyte maturation factor
    ÀûÇ÷±¸ ¼º¼÷ ÀÎÀÚ (îåúìϹà÷âÙì×í­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • aggregation
    ÀÀÁý, ÁýÇÕ, ±«»óÇü¼º, ÀÀ±«
  • erythrocyte
    ÀûÇ÷±¸
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸Ä§°­¼Óµµ, Ç÷ħ¼Óµµ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
IEA immediate early antigen; immunoelectroadsorption; immunoelectrophoretic analysis; infectious equine ...
EA early antigen; educational age; egg albumin; electric affinity; electrical activity; electroacupunct...
FE fatty ester; fecal emesis; fetal erythroblastosis; fetal erythrocyte; fluid extract; fluorescent ery...
agg agglutination; aggravation; aggregation
aggreg aggregated, aggregation
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AS Aggregation substance
PA Platelet aggregation
PAT Platelet aggregation test
RCA Red cell aggregation
RIPA Ristocetin induced platelet aggregation
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • aggregation defect
    ÀÀÁý °áÇÔ
  • ristocetin aggregation test
    ¸®½ºÅ似ƾ ÀÀÁý ½ÃÇè
  • agglutination of erythrocyte
    ÀûÇ÷±¸ ÀÀÁý
  • dysmorphic erythrocyte
    ÀÌÇü ÀûÇ÷±¸
  • elevated erythrocyte sedimentation rate
    Áõ°¡µÈ ÀûÇ÷±¸ ħ°­ ¼Óµµ
  • erythrocyte
    ÀûÇ÷±¸
    Ç÷±¸ÀÇ ÇÑ °¡Áö. °ñ¼ö¿¡¼­ »ý»êµÇ¸ç »ê¼Ò¸¦ ¿î¹ÝÇÏ´Â Çì¸ð±Û·ÎºóÀÌ ÀÖ´Ù. Ç÷»ö¼ÒÀÎ Çì¸ð±Û·Îºó ¶§¹®¿¡ ºÓ°Ô º¸ÀδÙ.
  • erythrocyte index
    ÀûÇ÷±¸ Áö¼ö
  • erythrocyte protoporphyrin test
    ÀûÇ÷±¸ ÇÁ·ÎÅäÆ÷¸£ÇǸ° ½ÃÇè
  • erythrocyte sedimentation rate
    ÀûÇ÷±¸ ħ°­ ¼Óµµ
    ÀÀ°íµÇÁö ¾ÊÀº Ç÷¾×À» ´ãÀº °ü¿¡¼­ ÀûÇ÷±¸°¡ °¡¶ó¾É´Â À²·Î¼­ ½Ã°£´ç mm·Î Ç¥½ÃÇÑ´Ù. ÀûÇ÷±¸ ħ°­ ¼ÓµµÀÇ Áõ°¡´Â ¿°ÁõÀÌ ÀÖ´Ù´Â °ÍÀ» ÀǹÌÇϳª Ưº°ÇÑ Àå¾Ö¿¡ ´ëÇØ °íÀ¯ÇÏÁö´Â ¾Ê´Ù.
  • erythrocyte sedimentation test
    ÀûÇ÷±¸ ħ°­ ½ÃÇè
  • polychromatic erythrocyte
    ´Ù¿°¼º ÀûÇ÷±¸
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
erythrocyte aggregation Aggregation of erythrocytes probably resulting from changes in the negative surface charge (zeta potential) of the cells caused by the dielectric effect of proteins in the surrounding plasma, especially asymmetric macromolecules like fibrinogen and gamma-globulin.
(12 Dec 1998)
erythrocyte aggregation, intravascular The massing or clumping of erythrocytes in intact blood vessels in response to injury or in certain diseases, interfering with adequate blood flow. It is also called sludging of blood and intravascular agglutination.
(12 Dec 1998)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
aggregation Massing of materials together as in clumping.
(18 Nov 1997)
receptor aggregation Chemically stimulated aggregation of cell surface receptors, which potentiates the action of the effector cell.
(12 Dec 1998)
cell aggregation The phenomenon by which dissociated cells intermixed in vitro tend to group themselves with cells of their own type.
(12 Dec 1998)
platelet aggregation The attachment of platelets to one another. This clumping together can be induced by a number of agents (e.g., thrombin, collagen) and is part of the mechanism leading to the formation of a thrombus.
(12 Dec 1998)
platelet aggregation inhibitors Drugs or agents which antagonise or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system.
(12 Dec 1998)
platelet aggregation test A test of the ability of platelets to adhere to each other and hence form a haemostatic plug to prevent bleeding; failure to aggregate occurs in several conditions, e.g., thrombasthenia, Von Willebrand's disease, and following administration of aspirin, phenylbutazone, and indomethacin; the test is conducted by quantitating the decrease in turbidity that occurs in platelet-rich plasma following the in vitro addition of one or several platelet-aggregating agents (e.g., ADP, epinephrine, or serotonin).
(05 Mar 2000)
familial aggregation <genetics> The occurrence of a trait in more members of a family than can be readily accounted for by chance; presumptive but not cogent evidence of the operation of genetic factors.
(05 Mar 2000)
rate, erythrocyte sedimentation A sedimentation rate, or sed rate , is a blood test that detects and is used to monitor inflammation activity. It is measured by recording the rate at which red blood cells (rbcs) sediment in a tube over time. It increases (the rbcs sediment faster) with more inflammation.
(12 Dec 1998)
erythrocyte A red blood cell.
(18 Nov 1997)
erythrocyte adherence phenomenon A phenomenon manifested by the adherence of antigen-antibody-complement complex to "indicator cells" (microorganisms, platelets, leukocytes, or erythrocytes), the reaction being sensitive and specific for the antigen and antibody in the complex.
Synonym: erythrocyte adherence phenomenon, immune adherence phenomenon, red cell adherence phenomenon.
(05 Mar 2000)
erythrocyte aging Senescence of the red blood cell. Lacking the organelles that make protein synthesis possible, the mature erythrocyte is incapable of self-repair, reproduction, and carrying out certain functions performed by other cells. This limits the average life span of an erythrocyte to 120 days.
(12 Dec 1998)
erythrocyte count A count of the number of red blood cells per unit volume in a sample of venous blood.
(12 Dec 1998)
erythrocyte deformability Ability of erythrocytes to change shape as they pass through narrow spaces, such as the microvasculature.
(12 Dec 1998)
erythrocyte ghost <cell biology> The membrane and cytoskeletal elements of the erythrocyte devoid of cytoplasmic contents, but preserving the original morphology.
(18 Nov 1997)
erythrocyte inclusions Pathologic inclusions occurring in erythrocytes.
(12 Dec 1998)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 1 ÆäÀÌÁö: 1
  • Erythrocyte Aggregation - »õâ The formation of clumps of RED BLOOD CELLS under low or non-flow conditions, resulting from the attraction forces between the red blood cells. The cells adhere to each other in rouleaux aggregates. Slight mechanical force, such as occurs in the circulation, is enough to disperse these aggregates. Stronger or weaker than normal aggregation may result from a variety of effects in the ERYTHROCYTE MEMBRANE or in BLOOD PLASMA. The degree of aggregation is affected by ERYTHROCYTE DEFORMABILITY, erythrocyte membrane sialylation, masking of negative surface charge by plasma proteins, etc. BLOOD VISCOSITY and the ERYTHROCYTE SEDIMENTATION RATE are affected by the amount of erythrocyte aggregation and are parameters used to measure the aggregation.
    Synonyms : Agglutination, Intravascular, Intravascular Agglutination, Intravascular Erythrocyte Aggregation, Rouleaux Formation, Erythrocyte, Agglutinations, Intravascular, Aggregation, Erythrocyte, Aggregation, Intravascular Erythrocyte, Aggregations, Erythrocyte
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocyte
    ÀûÇ÷±¸
  • aggregation
    ÁýÇÕ
  • aggregation
    ÁýÇÕ;Áý¼º;ÁýÇÕü;Áý´Ü
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á